US20130310919A1 - Elephant Trunk Thoracic Endograft and Delivery System - Google Patents

Elephant Trunk Thoracic Endograft and Delivery System Download PDF

Info

Publication number
US20130310919A1
US20130310919A1 US13/950,724 US201313950724A US2013310919A1 US 20130310919 A1 US20130310919 A1 US 20130310919A1 US 201313950724 A US201313950724 A US 201313950724A US 2013310919 A1 US2013310919 A1 US 2013310919A1
Authority
US
United States
Prior art keywords
stent
graft
delivery system
prosthesis
self
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/950,724
Inventor
Kristoff Nelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lifeshield Sciences LLC
Original Assignee
Lifeshield Sciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifeshield Sciences LLC filed Critical Lifeshield Sciences LLC
Priority to US13/950,724 priority Critical patent/US20130310919A1/en
Publication of US20130310919A1 publication Critical patent/US20130310919A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/962Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
    • A61F2/966Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/075Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • A61F2002/9583Means for holding the stent on the balloon, e.g. using protrusions, adhesives or an outer sleeve
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/005Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0058Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements soldered or brazed or welded
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0075Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable

Definitions

  • the present invention relates generally to a endoluminal prosthesis and a delivery system for deploying an endoluminal prosthesis within a body lumen. More particularly, the present invention provides a delivery device retaining an endoluminal prosthesis during delivery and additionally for the deployment of the endoluminal prosthesis at a target site within the lumen.
  • Endoluminal prostheses are typically used to repair, replace, or otherwise correct a diseased or damaged blood vessel.
  • An artery or vein may be diseased in a variety of ways.
  • the prosthesis may therefore be used to prevent or treat a wide variety of defects such as stenosis of the vessel, thrombosis, occlusion, or an aneurysm and dissections.
  • a stent is a generally longitudinal tubular device which is useful to open and support various lumens in the body.
  • stents may be used in the vascular system, urogenital tract and bile duct, as well as in a variety of other applications in the body.
  • Endovascular stents have become widely used for the treatment of stenosis, strictures, and aneurysms in various blood vessels. These devices are implanted within the vessel to open and/or reinforce collapsing or partially occluded sections of the vessel.
  • Stents are generally open ended and are radially expandable between a generally unexpanded insertion diameter and an expanded implantation diameter which is greater than the unexpanded insertion diameter. Stents are often flexible in configuration, which allows them to be inserted through and conform to tortuous pathways in the blood vessel. The stent is generally inserted in a radially compressed state and expanded either through a self-expanding mechanism, or through the use of balloon catheters.
  • a graft is another type of endoluminal prosthesis which is used to repair and replace various body vessels. Whereas a stent provides structural support to hold a damaged vessel open, a graft provides an artificial lumen through which blood may flow. Grafts are tubular devices which may be formed of a variety of materials, including textile and non-textile materials. Grafts also generally have an unexpanded insertion diameter and an expanded implantation diameter which is greater than the unexpanded diameter. The graft is sutured to the lumen to secure it in place.
  • both a stent and a graft it is also known to use both a stent and a graft to provide additional support for blood flow through weakened sections of a blood vessel.
  • a stent and a graft in combination is becoming increasingly important because the combination not only effectively allows the passage of blood therethrough, but also ensures the implant will remain open.
  • the use of a both a stent and a graft is available in various forms, such as a stent/graft composite or a multi-stage stent/graft where the stent secures the graft in place by pinning it between the stent and the vascular wall.
  • Such stent/graft composite prosthesis are described in U.S. Pat. No. 5,578,071 to Parodi, and U.S. Pat. No. 6,162,246 to Barone.
  • the delivery systems for the multi-stage stent/grafts are more complex because the different expansion properties between the graft and the stent, and the frictional relationship between the two in the sheath. In certain situations irregular expansion of the graft may occur, provoking folds on the graft that act as constrictor rings to limit the expansion of the stent.
  • prosthesis employing self-expanding stents typically experience longitudinal lengthening when compressed inside the sheath. When liberated inside the vascular lumen, they radially expand and longitudinally reduce. This change in shape poses a problem when a graft covers the outside of the stent because the grafts tend to deform due to the force exerted on the graft by the moving stent. Therefore multiple deployment systems are used when delivering one then one stent or graft.
  • Procedural success of the deployment of the stent/graft and the function of the stent/graft require accuracy of deployment and ability to reposition. Accuracy is affected by the environment of deployment being a continuous blood-flow, the location of the procedure in the vascular system, and the design of the stent/graft prosthesis and deployment device. For example, pressure from the high volume of blood flow, especially in the thoracic aorta, must be overcome by the delivery device in order to locate the site of deployment and accurately set the stent/graft prosthesis. The location of deployment adds to the difficulty of placement if, for example, a stent/graft prosthesis is used as an interventional repair of a thoracic aortic aneurysm.
  • a thoracic aortic aneurysm has the added complications of large amounts of blood flowing through this aorta, and the multiple outlet arteries disposing blood thereof.
  • Procedural success requires deploying the stent/graft such that the proximal and distal sections of the device are sited in the healthier tissue.
  • a stent/graft needs to anchor adjacent to or above the left subclavian. The placement is critical because the graft section must not cover the left subclavian to allow for blood flow to the left subclavian through the open cells of the stent.
  • the stent/graft prosthesis is deployed such that the graft section covers the left subclavian, then a blockage of the left subclavian would be formed by the graft. If the graft section is deployed too far downstream, then occlusion of the aneurysm may not be achieved.
  • the accuracy of the placement of the stent/graft prosthesis is critical. If the stent/graft prosthesis is deployed too low into the diseased section, there is the potential for rupturing the wall, and the aneurysm is not occluded by graft. Also, in certain instances the stent/graft prosthesis may not properly anchor and the prosthesis may pose a potential blockage problem. If the stent/graft prosthesis is anchored too high it may block or cut off other critical arteries.
  • the design of the stent/graft deployment device directly affects the performance and accuracy of the delivery device in the fluid flow environment. For example, the inability to reposition the stent/graft upon deployment, and difficulties associated with maneuvering the device within the arteries.
  • the design also attributes to the amount of retrograde pressure experienced from the blood flow during deployment. This retrograde pressure caused by the obstruction of blood flow causes the graft to twist, crumble and not properly unfold, and the stent may not anchor properly, move or shift during or after deployment.
  • a deployment device that accurately deploys a prosthesis, eliminating problems associated with concurrent deployment of a stent and graft, and blood flow obstruction, retrograde pressure.
  • a delivery device that offers the flexibility of post-deployment adjustments, and is least obstructive to the blood flow upon deployment.
  • the present invention provides a stent-graft and method of delivery of a device within a body lumen.
  • the system includes a stent/graft composite prosthesis and a deployment device.
  • the stent/graft composite prosthesis includes a radially balloon expandable or self-expanding stent and an elongated graft secured to the stent.
  • the deployment device includes an elongated outer sheath and a stent retaining means. The elongated outer sheath is overlying the graft and the outer sheath being retractable with respect to the graft.
  • the stent retaining means for maintaining the end of the composite in a radially compressed state. The stent retaining means being removable from the end for allowing the radial expansion thereof to attach to the graft to the body lumen.
  • a further version of the delivery system of the present invention includes a deployment device including an outer sheath, inner sheath and a stent retaining means.
  • the elongated outer sheath is for overlying the graft.
  • the elongated inner sheath is for overlying the stent and is retractable with respect to the stent.
  • the stent retaining means is for maintaining an end of the composite in a radially compressed state.
  • Yet another version of the delivery system of the present invention includes the deployment device including an elongated outer sheath, an inner sheath and a stent retaining means.
  • the elongated outer sheath is for overlying the stent and is retractable with respect to the stent.
  • the elongated inner sheath is for overlying the graft and is retractable with respect to the graft, and the stent retaining means is for maintaining an end to the composite in a radially compressed state.
  • the retaining means is retractable from the end for allowing the radial expansion thereof to attach to the graft to the body lumen.
  • a further version of the delivery system of the present invention includes a stent/graft composite prosthesis and a deployment device.
  • the stent/graft composite prosthesis comprising a first radially balloon expandable or self-expanding stent, an elongated graft secured to said first stent, and a second radially balloon expandable or self-expanding stent.
  • the deployment device includes an elongated outer sheath, an elongated inner sheath and a stent retaining means. The elongated outer sheath is for overlying the graft. The outer sheath is retractable with respect to the graft.
  • the elongated inner sheath is for overlying the second stent and is retractable with respect to the second stent.
  • the stent retaining means is for maintaining an end of the composite in a radially compressed state.
  • the retaining means is removable from the end for allowing said radial expansion thereof to attach said graft to said body lumen.
  • FIG. 1 is a schematic illustration of the delivery system of the present invention, having an outer sheath.
  • FIGS. 2 a , 2 b , and 2 c are schematic illustrations of the deployment device of FIG. 1 , having an outer sheath deploying the stent/graft of the present invention.
  • FIG. 3 is a schematic illustration of the delivery system of the present invention, having an outer sheath and an inner sheath.
  • FIGS. 4 a , 4 b and 4 c are schematic illustrations of the deployment device of FIG. 3 , having outer and inner sheath deploying the stent/graft of the present invention.
  • FIGS. 5 a , 5 b and 5 c are schematic illustrations of the deployment device of FIG. 3 , having outer and inner sheaths deploying the stent/graft and a second stent of the present invention.
  • FIG. 6 is a schematic illustration of the endoluminal prosthesis of the present invention.
  • the present invention relates to an endoluminal prosthesis and a delivery system for delivering a device within a body lumen.
  • the present invention addresses the problems associated with prior stent/graft delivery system, such as: graft deformities like creases and folds; distal migration during stent deployment; retrograde pressure and reflux; and inaccurate placement and inability to readjust positioning.
  • the delivery system 1 of the present invention include a stent/graft composite prosthesis 14 and a stent retaining device 5 .
  • the stent/graft composite prosthesis 14 is a generally tubular structure which includes a graft 4 and stent 2 .
  • the stent 2 is an elongated balloon expandable or self-expandable, tubular structure, with a pair of opposing ends and an open wall structure therebetween.
  • the stent has two diameters, the compressed diameter and the expanded diameter wherein the compressed diameter is substantially smaller than the expanded diameter.
  • the compressed diameter of the stent varies depending on the materials of construction and structure of the stent. In general, the compressed diameter must be small enough to allow for implantation through the vessel/lumen via a minimally invasive deployment system.
  • the expanded diameter needs to be substantially the same diameter as the vessel/lumen in which it is to replace or repair.
  • the expanded diameter needs to be large enough to allow the stent to sufficiently secure to the vessel/lumen wall without over expanding the vessel/lumen wall.
  • the stents may be capable of radially contracting, as well, and in this sense can best be described as radially distensible or deformable.
  • Self-expanding stents include those that have a spring-like action which causes the stent to radially expand, or stents which expand due to the memory properties of the stent material for a particular configuration at a certain temperature.
  • Nitinol is one material which has the ability to perform well while both in spring-like mode, as well as in a memory mode based on temperature.
  • Other materials are of course contemplated, such as stainless steel, platinum, gold, titanium and other biocompatible metals, as well as polymeric stents.
  • the configuration of the stent may also be chosen from a host of geometries.
  • wire stents can be fastened into a continuous helical pattern, with or without a wavelike or zig-zag in the wire, to form a radially deformable stent.
  • Individual rings or circular members can be linked together such as by struts, sutures, welding or interlacing or locking of the rings to form a tubular stent.
  • Tubular stents useful in the present invention also include those formed by etching or cutting a pattern from a tube. Such stents are often referred to as slotted stents.
  • stents may be formed by etching a pattern into a material or mold and depositing stent material in the pattern, such as by chemical vapor deposition or the like.
  • the stent 2 is longitudinally shorter than the attached graft 4 , defining an extending stent portion 2 a extending at one end beyond graft 4 .
  • the stent length may vary in length with respect to the graft.
  • the stent can be the same length as the graft having the stent running continuously the length of the graft, or the stent may be longitudinally longer than the graft wherein the stent extends beyond the graft.
  • the proximal end of the stent-graft composite must have an open architecture to allow blood passage during deployment (as in FIGS. 2 b and 4 b ).
  • the graft 4 is an elongated compressible generally tubular structure with a pair of opposing ends and a graft wall therebetween. Any known graft material and structure may be used to form the graft of the present invention.
  • the graft preferably has generally a tubular configuration.
  • the graft may be made from a variety of well known materials, provided they have the requisite strength characteristics and biocompatibility properties. Examples of such materials are polyester, polypropylene, polyethylene, polytetrafluoroethylene, expanded polytetrafluoroethylene and polyurethane, DACRON, TEFLON (polytetrafluoroethylene), and TEFLON coated DACRON.
  • the material can be extruded, knitted or woven, and can be warp or weft knitted.
  • the graft can also be coated or impregnated with a bio-erodible, or degradable material, such as albumin, collagen, heparin or similar coating material. Additionally, the graft could have a coating of a biologically inert material, such as TEFLON or porous polyurethane.
  • the diameter of the graft varies depending on the use but generally should be substantially the same diameter as the inside diameter of the stent or vessel/lumen in which it is to replace or repair.
  • the diameter should be large enough to allow for unobstructed blood flow and prevent retrograde pressure build-up in the blood flow. While cylindrical tubular configurations are shown, other tubular configurations may be employed.
  • the graft 4 extends circumferentially about the stent 2 , and the graft 4 is securably attached to the stent 2 .
  • the attachment of the graft 4 to the stent 2 may be accomplished by mechanically securing or bonding the graft 4 to the stent 2 .
  • the attachment of the graft 4 to the stent 2 may be at one end of the stent 2 or anywhere between the two ends of the stent 2 .
  • Mechanical securement includes, but is not limited to, the use of sutures, anchoring barbs, textile cuffs and the like.
  • Bonding includes, but is not limited to, chemical bonding, for instance, adhesive bonding, thermal bonding and the like.
  • the deployment device 5 of the present invention is designed for delivering and deploying the prosthesis 14 .
  • the device 5 includes an elongated outer sheath 6 which supports the prosthesis 14 in a compressed condition.
  • the delivery device 5 further adding a stent retaining member in the form of a nose cap 8 , which supports extending portion 2 a of stent 2 in compressed condition within outer sheath 6 .
  • the outer sheath 6 is an elongated generally tubular structure which longitudinally surrounds the stent/graft composite 14 .
  • the outer sheath 6 has a diameter which is sufficiently small so as to be readily inserted within a body lumen 12 as shown in FIG. 4 a .
  • the outer sheath 6 can be made of a variety of biocompatible material such as metal, glass or polymeric material; such as nylon, polyurethane, polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (ePTFE), fluorinated ethylene, propylene, polyimide, polyether ether ketone, and polybutylene terephthalate or any combination thereof.
  • the outer sheath 6 can be a thin wall tube, extruded or a sheet formed into a tube.
  • the nose cap 8 which retains extended portion 2 a of stent 2 may be formed of a brace or ring-like device that is removable to release the stent portion 2 a and allow for expansion.
  • the nose cap 8 is made from a material which is compatible with the body and small enough to be placed within a body lumen 12 . While a nose cap 8 is shown, the stent retaining means can be a removable wrap, net or crochet material; or biodegradable material, or bioabsorbable material which over time degrades, releasing the stent.
  • the deployment device 5 may further include a guide wire (not shown) to assist in placement of the composite prosthesis 14 , as known in the art.
  • FIGS. 2 a - 2 c shows the use of the delivery system 1 of FIG. 1 to deploy prosthesis 14 in a body lumen 12 .
  • FIG. 2 a shows the delivery system 1 positioned in the body lumen 12 .
  • the outer sheath 6 is retracted with respect to the prosthesis 14 in the direction of the arrow A as shown in FIG. 2 b .
  • the retraction of the outer sheath 6 progressively releases the stent 2 along its longitudinal extent and allows the stent 2 to radially expand.
  • the graft 4 which is positioned over stent 2 is also deployed by retraction of outer sheath 6 .
  • the graft 4 radially and longitudinally deploys by the radially expanding force of the attached stent 2 , and the pressure from the blood flowing, in the directions of the arrows B through the stent open wall structure and into the graft 4 lumen, as shown in FIG. 2 b .
  • the nose cap 8 holds the proximal end of the stent 2 so it can be repositioned. It also allows for continuous blood flow during deployment to overcome retrograde pressure.
  • the nose cap 8 is advanced away from the stent 2 in the direction of the arrow C as shown in FIG. 2 c . This allows stent portion 2 a to expand, with the radial expansion of the remainder of the stent 2 the prosthesis 14 is anchored in the body lumen 12 .
  • FIG. 3 and FIGS. 4 a - 4 c show a further embodiment of the invention.
  • the deployment device 25 as shown in FIG. 3 , includes the outer sheath 26 , an inner sheath 20 , and a nose cap 28 .
  • the deployment device 25 is prepared to deliver the stent/graft prosthesis 34 .
  • the inner sheath 20 is for overlying the stent/graft prosthesis 34 in a compressed state.
  • the inner sheath 20 is an elongated generally tubular structure which longitudinally surrounds the stent/graft prosthesis 34 .
  • the inner sheath is small enough to be inserted within the outer sheath 26 and easily movable therein.
  • the inner sheath 20 can be made of a variety of biocompatible material such as metal, glass or polymeric material; such as nylon, polyurethane, polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (ePTFE), fluorinated ethylene, propylene, polyimide, polyether ether ketone, and polybutylene terephthalate or any combinations thereof.
  • the inner sheath 20 can be a thin wall tube, braided, lined, extruded or a sheet formed into a tube.
  • the prosthesis 34 having a stent 22 and graft 24 is placed within the outer sheath 26 .
  • Extending portion 22 a of the stent 22 is radially compressed within the inner sheath 20 and the nose cap 28 .
  • the graft 24 is placed between the outer sheath 26 and the inner sheath 20 .
  • a guiding wire (not shown) may be employed to assist with placement of the delivery system 21 , as known in the art.
  • the outer sheath 26 is retracted, leaving the graft 24 exposed inside the lumen 12 , as shown in FIG. 4 a .
  • the graft 24 begins to radially and longitudinally deploy by the force of the blood flowing, in the direction of arrow B, through the open wall structure of the extending portion 22 a of stent 22 and through the graft 24 , as shown in FIG. 4 a.
  • the inner sheath 20 is gradually retracted, liberating stent 22 which was maintained in the compressed state by the inner sheath 20 , as shown in FIG. 4 b .
  • the gradual radial expansion of the stent 22 causes a correlative expansion of the graft 22 until it is pressed against vascular walls, as shown in FIG. 4 b .
  • the blood flow remains unobstructed, flowing through the open wall structure of the extending portion 22 a of stent 22 through the graft 24 , in direction of the arrows B in FIG. 4 b .
  • the deployment device 25 may still be repositioned and adjusted, since the prosthesis 34 is not yet completely anchored to the body lumen 12 .
  • the nose cap 8 is removed in the direction of the arrow F as shown in FIG. 4 c .
  • the extending portion 22 a of stent 22 radially expands and anchors the prosthesis 34 to the body lumen 12 , as shown in FIG. 4 c.
  • FIG. 6 and FIGS. 5 a - 5 c Yet a further embodiment of the present invention is shown in FIG. 6 and FIGS. 5 a - 5 c .
  • the delivery system 51 as shown in FIGS. 5 a - 5 c , delivers multiple stents and/or grafts.
  • the delivery system 51 includes an outer sheath 56 , an inner sheath 50 , and a nose cap 58 .
  • the deployment system 55 is prepared to deliver a stent/graft prosthesis 54 .
  • the prosthesis 64 has a first stent 52 , a graft 54 , and a second stent 60 .
  • First stent 52 is an elongated balloon expandable or self-expandable, tubular structure, with a pair of opposing ends and an open wall structure therebetween, as known in the art and above described.
  • First stent 52 is longitudinally shorter than the attached graft 54 , defining an extending stent portion 52 a extending at one end beyond graft 54 . While this embodiment is preferred, the first stent 52 may vary in length as the graft 54 having a stent running continuously the within the graft 54 .
  • the graft 54 is an elongated compressible generally tubular structure with a pair of opposing ends and a graft wall therebetween.
  • the graft 54 has an interior graft lumen 80 defined by the graft walls. Any known graft material and structure may be used to form the graft of the present invention.
  • the graft 54 preferably has generally a tubular configuration.
  • the graft 54 may be made from a variety of well known materials in the art and previously discussed.
  • the graft 54 extends circumferentially about the first stent 52 , and the graft 54 is securably attached to the first stent 52 , defining the graft attached end 54 a .
  • the attachment of the graft 54 to the first stent 52 may be accomplished by mechanically securing or bonding the graft 54 to the first stent 52 .
  • the attachment of the graft 54 to the first stent 52 may be at one end of the first stent 52 or anywhere between the two ends of the first stent 52 .
  • Mechanical securement includes, but is not limited to, the use of sutures, anchoring barbs, textile cuffs and the like. Bonding includes, but is not limited to, chemical bonding, for instance, adhesive bonding, thermal bonding and the like.
  • the graft 54 extends circumferentially about the second stent 60 , and the graft 54 is unattached to the second stent 60 .
  • Second stent 60 is an elongated balloon expandable or self-expandable tubular structure, with a pair of opposing ends and a open wall structure therebetween. Second stent 60 may be those known in the art and similar to stent 2 described above. Second stent 60 is unattached to the first stent 52 . Second stent 60 is adjacent to one end of first stent 52 and runs continuously in the graft lumen 80 the length of the graft 54 . While this is the preferred embodiment, second stent 60 can vary in length and be placed anywhere in the graft lumen 80 . For example, the second stent 60 can longitudinally extend beyond the length of the graft 54 , or the unattached end 54 b of the graft 54 can extend beyond the second stent 60 .
  • FIGS. 5 a - 5 c shows the use of delivery system 51 , similar to delivery system 21 of FIG. 3 , to deploy prosthesis 64 in a body lumen 12 .
  • Delivery system 51 includes a stent/graft prosthesis 64 and a deployment device 55 , as shown in FIG. 5 a .
  • the deployment device 55 includes an outer sheath 56 , an inner sheath 50 , and a nose cap 58 .
  • Second stent 60 is radially compressed and maintained in a compressed state by inner sheath 50 .
  • Nose cap 58 maintains the first stent 52 in a radially compressed condition.
  • the graft 54 is maintained in a compressed condition between the outer sheath 56 and the inner sheath 50 .
  • FIG. 5 a shows the delivery system 51 positioned in the body lumen 12 .
  • the outer sheath 56 is retracted exposing graft 54 inside the lumen 12 .
  • the blood flows through and around the extending portion 52 a of first stent 52 open wall structure into the graft 54 , in the direction of arrows B, as shown in FIG. 5 a .
  • the blood flow remains uninterrupted as it flows through and around the extending portion 52 a of first stent 52 and through graft 54 .
  • the nose cap 58 is then removed, allowing the extending portion 52 a of first stent 52 to radially expand and anchor the prosthesis 64 into the body lumen 12 , as shown in FIG. 5 b .
  • Graft 54 is radially expanded by the force of deployment of stent 52 and blood flow. As shown in FIG. 5 c the inner sheath 50 is retracted allowing the second stent 60 to radially expand securing graft 54 to the body lumen 12 .
  • FIGS. 5 a - 5 c Another scenario of FIGS. 5 a - 5 c is the deployment device 55 is used with one continuous stent and the nose cap 58 is removed to allow the extending portion of the stent to anchor the prosthesis and the inner sheath 50 is later retracted to allow the stent to fully deploy. Deploying a stent at the distal end of the graft secures the graft and prevents distal leakage into an aneurysm.

Abstract

A delivery system for delivering a device within a body lumen. The delivery system includes a self-expanding stent/graft composite prosthesis and a deployment device. The deployment device includes an outer sheath which overlies the graft, and a stent retaining means for maintaining the one end of the stent in a radially compressed state. The outer sheath is retractable with respect to the graft, and the stent retaining means is removable to allow the stent end to radially expand. The deployment device may further include an inner sheath to overlie the composite and is retractable with respect to the composite. An endoluminal prosthesis including a graft attached to one stent and a second stent unattached within the graft lumen.

Description

    RELATED APPLICATIONS
  • This application is a continuation application of U.S. Ser. No. 10/234,070 filed Sep. 3, 2002.
  • FIELD OF THE INVENTION
  • The present invention relates generally to a endoluminal prosthesis and a delivery system for deploying an endoluminal prosthesis within a body lumen. More particularly, the present invention provides a delivery device retaining an endoluminal prosthesis during delivery and additionally for the deployment of the endoluminal prosthesis at a target site within the lumen.
  • BACKGROUND OF THE INVENTION
  • Endoluminal prostheses are typically used to repair, replace, or otherwise correct a diseased or damaged blood vessel. An artery or vein may be diseased in a variety of ways. The prosthesis may therefore be used to prevent or treat a wide variety of defects such as stenosis of the vessel, thrombosis, occlusion, or an aneurysm and dissections.
  • One type of endoluminal prosthesis used in treatment and repair of diseases in various blood vessels is a stent. A stent is a generally longitudinal tubular device which is useful to open and support various lumens in the body. For example, stents may be used in the vascular system, urogenital tract and bile duct, as well as in a variety of other applications in the body. Endovascular stents have become widely used for the treatment of stenosis, strictures, and aneurysms in various blood vessels. These devices are implanted within the vessel to open and/or reinforce collapsing or partially occluded sections of the vessel.
  • Stents are generally open ended and are radially expandable between a generally unexpanded insertion diameter and an expanded implantation diameter which is greater than the unexpanded insertion diameter. Stents are often flexible in configuration, which allows them to be inserted through and conform to tortuous pathways in the blood vessel. The stent is generally inserted in a radially compressed state and expanded either through a self-expanding mechanism, or through the use of balloon catheters.
  • A graft is another type of endoluminal prosthesis which is used to repair and replace various body vessels. Whereas a stent provides structural support to hold a damaged vessel open, a graft provides an artificial lumen through which blood may flow. Grafts are tubular devices which may be formed of a variety of materials, including textile and non-textile materials. Grafts also generally have an unexpanded insertion diameter and an expanded implantation diameter which is greater than the unexpanded diameter. The graft is sutured to the lumen to secure it in place.
  • It is also known to use both a stent and a graft to provide additional support for blood flow through weakened sections of a blood vessel. In endovascular applications the use of a stent and a graft in combination is becoming increasingly important because the combination not only effectively allows the passage of blood therethrough, but also ensures the implant will remain open. The use of a both a stent and a graft is available in various forms, such as a stent/graft composite or a multi-stage stent/graft where the stent secures the graft in place by pinning it between the stent and the vascular wall. Such stent/graft composite prosthesis are described in U.S. Pat. No. 5,578,071 to Parodi, and U.S. Pat. No. 6,162,246 to Barone.
  • It is also known to provide delivery systems for delivering such prostheses intraluminally. These standard delivery systems generally include catheters with the prosthesis removably mounted to the distal end of the catheter. Quite often a catheter, introducer sheath, or other similar retaining means is disposed over the prosthesis to removably support the prosthesis on the catheter. Once the prosthesis is situated in the target site in the lumen, the catheter is removed by pulling the sheath or retaining means away from the prosthesis to allow the expansion.
  • The delivery systems for the multi-stage stent/grafts are more complex because the different expansion properties between the graft and the stent, and the frictional relationship between the two in the sheath. In certain situations irregular expansion of the graft may occur, provoking folds on the graft that act as constrictor rings to limit the expansion of the stent. Moreover, prosthesis employing self-expanding stents typically experience longitudinal lengthening when compressed inside the sheath. When liberated inside the vascular lumen, they radially expand and longitudinally reduce. This change in shape poses a problem when a graft covers the outside of the stent because the grafts tend to deform due to the force exerted on the graft by the moving stent. Therefore multiple deployment systems are used when delivering one then one stent or graft.
  • Procedural success of the deployment of the stent/graft and the function of the stent/graft require accuracy of deployment and ability to reposition. Accuracy is affected by the environment of deployment being a continuous blood-flow, the location of the procedure in the vascular system, and the design of the stent/graft prosthesis and deployment device. For example, pressure from the high volume of blood flow, especially in the thoracic aorta, must be overcome by the delivery device in order to locate the site of deployment and accurately set the stent/graft prosthesis. The location of deployment adds to the difficulty of placement if, for example, a stent/graft prosthesis is used as an interventional repair of a thoracic aortic aneurysm. A thoracic aortic aneurysm has the added complications of large amounts of blood flowing through this aorta, and the multiple outlet arteries disposing blood thereof. Procedural success requires deploying the stent/graft such that the proximal and distal sections of the device are sited in the healthier tissue. In a very diseased thoracic aorta where the aneurysm is up to the left subclavian or left common carotid, a stent/graft needs to anchor adjacent to or above the left subclavian. The placement is critical because the graft section must not cover the left subclavian to allow for blood flow to the left subclavian through the open cells of the stent. If the stent/graft prosthesis is deployed such that the graft section covers the left subclavian, then a blockage of the left subclavian would be formed by the graft. If the graft section is deployed too far downstream, then occlusion of the aneurysm may not be achieved.
  • The accuracy of the placement of the stent/graft prosthesis is critical. If the stent/graft prosthesis is deployed too low into the diseased section, there is the potential for rupturing the wall, and the aneurysm is not occluded by graft. Also, in certain instances the stent/graft prosthesis may not properly anchor and the prosthesis may pose a potential blockage problem. If the stent/graft prosthesis is anchored too high it may block or cut off other critical arteries.
  • The design of the stent/graft deployment device directly affects the performance and accuracy of the delivery device in the fluid flow environment. For example, the inability to reposition the stent/graft upon deployment, and difficulties associated with maneuvering the device within the arteries. The design also attributes to the amount of retrograde pressure experienced from the blood flow during deployment. This retrograde pressure caused by the obstruction of blood flow causes the graft to twist, crumble and not properly unfold, and the stent may not anchor properly, move or shift during or after deployment.
  • Thus, there is a need in the art for a deployment device that accurately deploys a prosthesis, eliminating problems associated with concurrent deployment of a stent and graft, and blood flow obstruction, retrograde pressure. There is a need for a delivery device that offers the flexibility of post-deployment adjustments, and is least obstructive to the blood flow upon deployment.
  • SUMMARY OF THE INVENTION
  • The present invention provides a stent-graft and method of delivery of a device within a body lumen. The system includes a stent/graft composite prosthesis and a deployment device. The stent/graft composite prosthesis includes a radially balloon expandable or self-expanding stent and an elongated graft secured to the stent. The deployment device includes an elongated outer sheath and a stent retaining means. The elongated outer sheath is overlying the graft and the outer sheath being retractable with respect to the graft. The stent retaining means for maintaining the end of the composite in a radially compressed state. The stent retaining means being removable from the end for allowing the radial expansion thereof to attach to the graft to the body lumen.
  • A further version of the delivery system of the present invention includes a deployment device including an outer sheath, inner sheath and a stent retaining means. The elongated outer sheath is for overlying the graft. The elongated inner sheath is for overlying the stent and is retractable with respect to the stent. The stent retaining means is for maintaining an end of the composite in a radially compressed state.
  • Yet another version of the delivery system of the present invention includes the deployment device including an elongated outer sheath, an inner sheath and a stent retaining means. The elongated outer sheath is for overlying the stent and is retractable with respect to the stent. The elongated inner sheath is for overlying the graft and is retractable with respect to the graft, and the stent retaining means is for maintaining an end to the composite in a radially compressed state. The retaining means is retractable from the end for allowing the radial expansion thereof to attach to the graft to the body lumen.
  • A further version of the delivery system of the present invention includes a stent/graft composite prosthesis and a deployment device. The stent/graft composite prosthesis comprising a first radially balloon expandable or self-expanding stent, an elongated graft secured to said first stent, and a second radially balloon expandable or self-expanding stent. The deployment device includes an elongated outer sheath, an elongated inner sheath and a stent retaining means. The elongated outer sheath is for overlying the graft. The outer sheath is retractable with respect to the graft. The elongated inner sheath is for overlying the second stent and is retractable with respect to the second stent. The stent retaining means is for maintaining an end of the composite in a radially compressed state. The retaining means is removable from the end for allowing said radial expansion thereof to attach said graft to said body lumen.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a schematic illustration of the delivery system of the present invention, having an outer sheath.
  • FIGS. 2 a, 2 b, and 2 c are schematic illustrations of the deployment device of FIG. 1, having an outer sheath deploying the stent/graft of the present invention.
  • FIG. 3 is a schematic illustration of the delivery system of the present invention, having an outer sheath and an inner sheath.
  • FIGS. 4 a, 4 b and 4 c are schematic illustrations of the deployment device of FIG. 3, having outer and inner sheath deploying the stent/graft of the present invention.
  • FIGS. 5 a, 5 b and 5 c are schematic illustrations of the deployment device of FIG. 3, having outer and inner sheaths deploying the stent/graft and a second stent of the present invention.
  • FIG. 6 is a schematic illustration of the endoluminal prosthesis of the present invention.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The present invention relates to an endoluminal prosthesis and a delivery system for delivering a device within a body lumen.
  • The present invention addresses the problems associated with prior stent/graft delivery system, such as: graft deformities like creases and folds; distal migration during stent deployment; retrograde pressure and reflux; and inaccurate placement and inability to readjust positioning.
  • The delivery system 1 of the present invention, as shown in FIG. 1 and FIGS. 2 a-2 c, include a stent/graft composite prosthesis 14 and a stent retaining device 5. The stent/graft composite prosthesis 14 is a generally tubular structure which includes a graft 4 and stent 2. The stent 2 is an elongated balloon expandable or self-expandable, tubular structure, with a pair of opposing ends and an open wall structure therebetween.
  • As is known in the art, the stent has two diameters, the compressed diameter and the expanded diameter wherein the compressed diameter is substantially smaller than the expanded diameter. The compressed diameter of the stent varies depending on the materials of construction and structure of the stent. In general, the compressed diameter must be small enough to allow for implantation through the vessel/lumen via a minimally invasive deployment system. The expanded diameter needs to be substantially the same diameter as the vessel/lumen in which it is to replace or repair. The expanded diameter needs to be large enough to allow the stent to sufficiently secure to the vessel/lumen wall without over expanding the vessel/lumen wall.
  • Various stent types and stent constructions may be employed in the invention. The stents may be capable of radially contracting, as well, and in this sense can best be described as radially distensible or deformable. Self-expanding stents include those that have a spring-like action which causes the stent to radially expand, or stents which expand due to the memory properties of the stent material for a particular configuration at a certain temperature. Nitinol is one material which has the ability to perform well while both in spring-like mode, as well as in a memory mode based on temperature. Other materials are of course contemplated, such as stainless steel, platinum, gold, titanium and other biocompatible metals, as well as polymeric stents.
  • The configuration of the stent may also be chosen from a host of geometries. For example, wire stents can be fastened into a continuous helical pattern, with or without a wavelike or zig-zag in the wire, to form a radially deformable stent. Individual rings or circular members can be linked together such as by struts, sutures, welding or interlacing or locking of the rings to form a tubular stent. Tubular stents useful in the present invention also include those formed by etching or cutting a pattern from a tube. Such stents are often referred to as slotted stents. Furthermore, stents may be formed by etching a pattern into a material or mold and depositing stent material in the pattern, such as by chemical vapor deposition or the like.
  • As shown in FIG. 1 the stent 2 is longitudinally shorter than the attached graft 4, defining an extending stent portion 2 a extending at one end beyond graft 4. While this embodiment is preferred, the stent length may vary in length with respect to the graft. For example, the stent can be the same length as the graft having the stent running continuously the length of the graft, or the stent may be longitudinally longer than the graft wherein the stent extends beyond the graft. The proximal end of the stent-graft composite must have an open architecture to allow blood passage during deployment (as in FIGS. 2 b and 4 b).
  • The graft 4 is an elongated compressible generally tubular structure with a pair of opposing ends and a graft wall therebetween. Any known graft material and structure may be used to form the graft of the present invention. The graft preferably has generally a tubular configuration. The graft may be made from a variety of well known materials, provided they have the requisite strength characteristics and biocompatibility properties. Examples of such materials are polyester, polypropylene, polyethylene, polytetrafluoroethylene, expanded polytetrafluoroethylene and polyurethane, DACRON, TEFLON (polytetrafluoroethylene), and TEFLON coated DACRON. The material can be extruded, knitted or woven, and can be warp or weft knitted. The graft can also be coated or impregnated with a bio-erodible, or degradable material, such as albumin, collagen, heparin or similar coating material. Additionally, the graft could have a coating of a biologically inert material, such as TEFLON or porous polyurethane.
  • In general, the diameter of the graft varies depending on the use but generally should be substantially the same diameter as the inside diameter of the stent or vessel/lumen in which it is to replace or repair. The diameter should be large enough to allow for unobstructed blood flow and prevent retrograde pressure build-up in the blood flow. While cylindrical tubular configurations are shown, other tubular configurations may be employed.
  • The graft 4 extends circumferentially about the stent 2, and the graft 4 is securably attached to the stent 2. The attachment of the graft 4 to the stent 2 may be accomplished by mechanically securing or bonding the graft 4 to the stent 2. The attachment of the graft 4 to the stent 2 may be at one end of the stent 2 or anywhere between the two ends of the stent 2. Mechanical securement includes, but is not limited to, the use of sutures, anchoring barbs, textile cuffs and the like. Bonding includes, but is not limited to, chemical bonding, for instance, adhesive bonding, thermal bonding and the like.
  • As shown in FIG. 1 and FIGS. 2 a-2 c, the deployment device 5 of the present invention is designed for delivering and deploying the prosthesis 14. The device 5 includes an elongated outer sheath 6 which supports the prosthesis 14 in a compressed condition.
  • The delivery device 5 further adding a stent retaining member in the form of a nose cap 8, which supports extending portion 2 a of stent 2 in compressed condition within outer sheath 6.
  • The outer sheath 6 is an elongated generally tubular structure which longitudinally surrounds the stent/graft composite 14. The outer sheath 6 has a diameter which is sufficiently small so as to be readily inserted within a body lumen 12 as shown in FIG. 4 a. The outer sheath 6 can be made of a variety of biocompatible material such as metal, glass or polymeric material; such as nylon, polyurethane, polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (ePTFE), fluorinated ethylene, propylene, polyimide, polyether ether ketone, and polybutylene terephthalate or any combination thereof. The outer sheath 6 can be a thin wall tube, extruded or a sheet formed into a tube.
  • The nose cap 8, which retains extended portion 2 a of stent 2 may be formed of a brace or ring-like device that is removable to release the stent portion 2 a and allow for expansion. The nose cap 8 is made from a material which is compatible with the body and small enough to be placed within a body lumen 12. While a nose cap 8 is shown, the stent retaining means can be a removable wrap, net or crochet material; or biodegradable material, or bioabsorbable material which over time degrades, releasing the stent.
  • The deployment device 5 may further include a guide wire (not shown) to assist in placement of the composite prosthesis 14, as known in the art.
  • FIGS. 2 a-2 c shows the use of the delivery system 1 of FIG. 1 to deploy prosthesis 14 in a body lumen 12.
  • FIG. 2 a shows the delivery system 1 positioned in the body lumen 12. The outer sheath 6 is retracted with respect to the prosthesis 14 in the direction of the arrow A as shown in FIG. 2 b. The retraction of the outer sheath 6 progressively releases the stent 2 along its longitudinal extent and allows the stent 2 to radially expand. The graft 4 which is positioned over stent 2 is also deployed by retraction of outer sheath 6. The graft 4 radially and longitudinally deploys by the radially expanding force of the attached stent 2, and the pressure from the blood flowing, in the directions of the arrows B through the stent open wall structure and into the graft 4 lumen, as shown in FIG. 2 b. The nose cap 8 holds the proximal end of the stent 2 so it can be repositioned. It also allows for continuous blood flow during deployment to overcome retrograde pressure.
  • After deployment of the graft 4 and the major portion of stent 2, the nose cap 8 is advanced away from the stent 2 in the direction of the arrow C as shown in FIG. 2 c. This allows stent portion 2 a to expand, with the radial expansion of the remainder of the stent 2 the prosthesis 14 is anchored in the body lumen 12.
  • FIG. 3 and FIGS. 4 a-4 c show a further embodiment of the invention. The deployment device 25, as shown in FIG. 3, includes the outer sheath 26, an inner sheath 20, and a nose cap 28. The deployment device 25 is prepared to deliver the stent/graft prosthesis 34.
  • The inner sheath 20 is for overlying the stent/graft prosthesis 34 in a compressed state. The inner sheath 20 is an elongated generally tubular structure which longitudinally surrounds the stent/graft prosthesis 34. The inner sheath is small enough to be inserted within the outer sheath 26 and easily movable therein. The inner sheath 20 can be made of a variety of biocompatible material such as metal, glass or polymeric material; such as nylon, polyurethane, polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (ePTFE), fluorinated ethylene, propylene, polyimide, polyether ether ketone, and polybutylene terephthalate or any combinations thereof. The inner sheath 20 can be a thin wall tube, braided, lined, extruded or a sheet formed into a tube.
  • As shown in FIG. 3, the prosthesis 34 having a stent 22 and graft 24 is placed within the outer sheath 26. Extending portion 22 a of the stent 22 is radially compressed within the inner sheath 20 and the nose cap 28. The graft 24 is placed between the outer sheath 26 and the inner sheath 20. A guiding wire (not shown) may be employed to assist with placement of the delivery system 21, as known in the art.
  • Once the delivery system 21 is in the desired location the outer sheath 26 is retracted, leaving the graft 24 exposed inside the lumen 12, as shown in FIG. 4 a. The graft 24 begins to radially and longitudinally deploy by the force of the blood flowing, in the direction of arrow B, through the open wall structure of the extending portion 22 a of stent 22 and through the graft 24, as shown in FIG. 4 a.
  • The inner sheath 20 is gradually retracted, liberating stent 22 which was maintained in the compressed state by the inner sheath 20, as shown in FIG. 4 b. The gradual radial expansion of the stent 22 causes a correlative expansion of the graft 22 until it is pressed against vascular walls, as shown in FIG. 4 b. During the retraction of the inner sheath 20 the blood flow remains unobstructed, flowing through the open wall structure of the extending portion 22 a of stent 22 through the graft 24, in direction of the arrows B in FIG. 4 b. The deployment device 25 may still be repositioned and adjusted, since the prosthesis 34 is not yet completely anchored to the body lumen 12. Once in the desired position the nose cap 8 is removed in the direction of the arrow F as shown in FIG. 4 c. The extending portion 22 a of stent 22 radially expands and anchors the prosthesis 34 to the body lumen 12, as shown in FIG. 4 c.
  • Yet a further embodiment of the present invention is shown in FIG. 6 and FIGS. 5 a-5 c. The delivery system 51, as shown in FIGS. 5 a-5 c, delivers multiple stents and/or grafts. The delivery system 51 includes an outer sheath 56, an inner sheath 50, and a nose cap 58. The deployment system 55 is prepared to deliver a stent/graft prosthesis 54.
  • As shown in FIG. 6, the prosthesis 64 has a first stent 52, a graft 54, and a second stent 60. First stent 52 is an elongated balloon expandable or self-expandable, tubular structure, with a pair of opposing ends and an open wall structure therebetween, as known in the art and above described. First stent 52 is longitudinally shorter than the attached graft 54, defining an extending stent portion 52 a extending at one end beyond graft 54. While this embodiment is preferred, the first stent 52 may vary in length as the graft 54 having a stent running continuously the within the graft 54.
  • The graft 54 is an elongated compressible generally tubular structure with a pair of opposing ends and a graft wall therebetween. The graft 54 has an interior graft lumen 80 defined by the graft walls. Any known graft material and structure may be used to form the graft of the present invention. The graft 54 preferably has generally a tubular configuration. The graft 54 may be made from a variety of well known materials in the art and previously discussed.
  • The graft 54 extends circumferentially about the first stent 52, and the graft 54 is securably attached to the first stent 52, defining the graft attached end 54 a. The attachment of the graft 54 to the first stent 52 may be accomplished by mechanically securing or bonding the graft 54 to the first stent 52. The attachment of the graft 54 to the first stent 52 may be at one end of the first stent 52 or anywhere between the two ends of the first stent 52. Mechanical securement includes, but is not limited to, the use of sutures, anchoring barbs, textile cuffs and the like. Bonding includes, but is not limited to, chemical bonding, for instance, adhesive bonding, thermal bonding and the like.
  • The graft 54 extends circumferentially about the second stent 60, and the graft 54 is unattached to the second stent 60. Second stent 60 is an elongated balloon expandable or self-expandable tubular structure, with a pair of opposing ends and a open wall structure therebetween. Second stent 60 may be those known in the art and similar to stent 2 described above. Second stent 60 is unattached to the first stent 52. Second stent 60 is adjacent to one end of first stent 52 and runs continuously in the graft lumen 80 the length of the graft 54. While this is the preferred embodiment, second stent 60 can vary in length and be placed anywhere in the graft lumen 80. For example, the second stent 60 can longitudinally extend beyond the length of the graft 54, or the unattached end 54 b of the graft 54 can extend beyond the second stent 60.
  • FIGS. 5 a-5 c shows the use of delivery system 51, similar to delivery system 21 of FIG. 3, to deploy prosthesis 64 in a body lumen 12. Delivery system 51 includes a stent/graft prosthesis 64 and a deployment device 55, as shown in FIG. 5 a. The deployment device 55 includes an outer sheath 56, an inner sheath 50, and a nose cap 58. Second stent 60 is radially compressed and maintained in a compressed state by inner sheath 50. Nose cap 58 maintains the first stent 52 in a radially compressed condition. The graft 54 is maintained in a compressed condition between the outer sheath 56 and the inner sheath 50.
  • FIG. 5 a shows the delivery system 51 positioned in the body lumen 12. The outer sheath 56 is retracted exposing graft 54 inside the lumen 12. The blood flows through and around the extending portion 52 a of first stent 52 open wall structure into the graft 54, in the direction of arrows B, as shown in FIG. 5 a. The blood flow remains uninterrupted as it flows through and around the extending portion 52 a of first stent 52 and through graft 54. The nose cap 58 is then removed, allowing the extending portion 52 a of first stent 52 to radially expand and anchor the prosthesis 64 into the body lumen 12, as shown in FIG. 5 b. Graft 54 is radially expanded by the force of deployment of stent 52 and blood flow. As shown in FIG. 5 c the inner sheath 50 is retracted allowing the second stent 60 to radially expand securing graft 54 to the body lumen 12. Another scenario of FIGS. 5 a-5 c is the deployment device 55 is used with one continuous stent and the nose cap 58 is removed to allow the extending portion of the stent to anchor the prosthesis and the inner sheath 50 is later retracted to allow the stent to fully deploy. Deploying a stent at the distal end of the graft secures the graft and prevents distal leakage into an aneurysm.
  • It will be appreciated that the present invention has been described herein with reference to certain preferred or exemplary embodiments. The preferred or exemplary embodiments described herein may be modified, changed, added to or deviated from without departing from the intent, spirit and scope of the present invention. It is intended that all such additions, modifications, amendments and/or deviations be included within the scope of the claims appended hereto.

Claims (30)

1. A prosthesis delivery system comprising:
a self-expandable stent-graft prosthesis with a first end, a second end and a length therebetween; and
a deployment device comprising:
an elongated outer sheath, the elongated outer sheath overlying the self-expandable stent-graft prosthesis and maintaining the first end of the self-expandable stent-graft prosthesis in a radially compressed state, said elongated outer sheath being retractable with respect to the self-expandable stent-graft prosthesis for radial self-expansion of the first end of the self-expandable stent-graft prosthesis from the radially compressed state upon retraction of the elongated outer sheath; and
a retaining member, the retaining member overlying and maintaining the second end of the self-expandable stent-graft prosthesis in a radially compressed state, the second end of the self-expandable stent-graft prosthesis being positioned inside the retaining member, the retaining member being independently retractable from the second end of the self-expandable stent-graft prosthesis for radial self-expansion of the second end of the self-expandable stent-graft prosthesis from the radially compressed state upon retraction of the retaining member;
wherein only the elongated outer sheath maintains the first end of the self-expandable stent-graft prosthesis in the radially compressed state and only the stent-graft retaining member maintains the second end of the self-expandable stent-graft prosthesis in the radially compressed state, and the retaining member and the elongated outer sheath are retractable in opposite directions.
2. The prosthesis delivery system of claim 1, wherein the self-expandable stent-graft prosthesis includes either a wire stent in a continuous helical pattern or a stent with individual rings linked together.
3. The prosthesis delivery system of claim 1, wherein the stent of the self-expandable stent-graft prosthesis forms the second end of the self-expandable stent-graft prosthesis and has a length greater than a length of the graft of the self-expandable stent-graft prosthesis.
4. The prosthesis delivery system of claim 1, wherein the stent and graft of the self-expandable stent-graft prosthesis are secured to one another by sutures.
5. The prosthesis delivery system of claim 1, wherein the self-expandable stent-graft prosthesis comprises a stent at least partially formed of a material with memory properties based on temperature.
6. The prosthesis delivery system of claim 5, wherein the material is nitinol.
7. The prosthesis delivery system of claim 1, wherein the self-expandable stent-graft prosthesis comprises a stent at least partially formed by cutting a pattern from a tube.
8. The prosthesis delivery system of claim 1, wherein the self-expandable stent-graft prosthesis comprises a stent at least partially formed by etching a pattern from a tube.
9. The prosthesis delivery system of claim 1, the elongated outer sheath having a greater longitudinal length than the retaining member.
10. The prosthesis delivery system of claim 1, wherein the elongated outer sheath and the retaining member are side by side so that the elongated outer sheath does not overlap the retaining member.
11. The prosthesis delivery system of claim 1, wherein an entirety of the length of the self-expandable stent-graft prosthesis is maintained in the radially compressed state by the elongated outer sheath and the retaining member.
12. A delivery system comprising:
an elongated outer sheath, the elongated outer sheath having a sheath length, the elongated outer sheath being retractable in a first direction;
a retaining member, the retaining member having a member length less than the sheath length, the retaining member being positioned longitudinally adjacent to the elongated outer sheath, the retaining member being retractable in a second direction opposite the first direction;
a stent-graft having a first end, a second end, and a length therebetween, the stent-graft having a radially compressed state;
wherein an entirety of the length of the stent-graft is maintained in the radially compressed state by the elongated outer sheath and the retaining member with the first end of the stent-graft being maintained in the radially compressed state only by the elongated outer sheath and the second end of the stent-graft being maintained in the radially compressed state only by the retaining member.
13. The delivery system of claim 12, wherein an entire length of the retaining member is retracted in the second direction.
14. The delivery system of claim 12, the stent-graft being self-expandable.
15. The delivery system of claim 12, wherein the stent and graft are secured to one another by sutures.
16. The delivery system of claim 12, wherein the stent-graft comprises a stent at least partially formed of a material with memory properties based on temperature.
17. The delivery system of claim 16, wherein the material is nitinol.
18. The delivery system of claim 12, wherein the stent-graft comprises a stent at least partially formed by cutting a pattern from a tube.
19. The delivery system of claim 12, wherein the stent-graft comprises a stent at least partially formed by etching a pattern from a tube.
20. The delivery system of claim 12, wherein the stent-graft includes either a wire stent in a continuous helical pattern or a stent with individual rings linked together.
21. The delivery system of claim 12, wherein the stent forms the second end of the stent-graft and has a length greater than a length of the graft.
22. A delivery system for a stent-graft, the stent-graft having a first end, a second end and a length therebetween, the delivery system comprising:
an elongated outer sheath, the elongated outer sheath being retractable from the stent-graft in a first direction;
a retaining member positioned longitudinally adjacent to the elongated outer sheath, the retaining member being retractable from the stent-graft in a second direction opposite the first direction;
the delivery system having a first configuration wherein:
both the elongated outer sheath and the retaining member maintain an entirety of the length of the stent-graft in a radially compressed state with only the elongated outer sheath maintaining the first end of the stent-graft in the radially compressed state and only the stent-graft retaining member maintaining the second end of the stent-graft in the radially compressed state;
wherein the delivery system is in the first configuration.
23. The delivery system of claim 22, the delivery system configured to have:
a second configuration wherein only a portion of the stent-graft is in a radially compressed state with only the retaining member maintaining the stent-graft in a radially compressed state.
24. The delivery system of claim 22, the stent-graft being self-expandable.
25. The delivery system of claim 22, wherein the stent-graft comprises a stent at least partially formed of a material with memory properties based on temperature.
26. The delivery system of claim 25, wherein the material is nitinol.
27. The delivery system of claim 22, wherein the stent-graft comprises a stent at least partially formed by cutting a pattern from a tube.
28. The delivery system of claim 22, wherein the stent-graft comprises a stent at least partially formed by etching a pattern from a tube.
29. The delivery system of claim 22, wherein the stent-graft includes either a wire stent in a continuous helical pattern or a stent with individual rings linked together.
30. The delivery system of claim 22, wherein the stent of the stent-graft forms the second end of the stent-graft and has a length greater than a length of the graft of the stent-graft.
US13/950,724 2002-09-03 2013-07-25 Elephant Trunk Thoracic Endograft and Delivery System Abandoned US20130310919A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/950,724 US20130310919A1 (en) 2002-09-03 2013-07-25 Elephant Trunk Thoracic Endograft and Delivery System

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/234,070 US8518096B2 (en) 2002-09-03 2002-09-03 Elephant trunk thoracic endograft and delivery system
US13/950,724 US20130310919A1 (en) 2002-09-03 2013-07-25 Elephant Trunk Thoracic Endograft and Delivery System

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/234,070 Continuation US8518096B2 (en) 2002-09-03 2002-09-03 Elephant trunk thoracic endograft and delivery system

Publications (1)

Publication Number Publication Date
US20130310919A1 true US20130310919A1 (en) 2013-11-21

Family

ID=31977365

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/234,070 Expired - Fee Related US8518096B2 (en) 2002-09-03 2002-09-03 Elephant trunk thoracic endograft and delivery system
US13/950,724 Abandoned US20130310919A1 (en) 2002-09-03 2013-07-25 Elephant Trunk Thoracic Endograft and Delivery System

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/234,070 Expired - Fee Related US8518096B2 (en) 2002-09-03 2002-09-03 Elephant trunk thoracic endograft and delivery system

Country Status (6)

Country Link
US (2) US8518096B2 (en)
EP (1) EP1545397A1 (en)
JP (1) JP4624103B2 (en)
AU (1) AU2003251299A1 (en)
CA (1) CA2497704A1 (en)
WO (1) WO2004021932A1 (en)

Families Citing this family (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0121980D0 (en) 2001-09-11 2001-10-31 Cathnet Science Holding As Expandable stent
US7892273B2 (en) * 2001-12-03 2011-02-22 Xtent, Inc. Custom length stent apparatus
US20040186551A1 (en) * 2003-01-17 2004-09-23 Xtent, Inc. Multiple independent nested stent structures and methods for their preparation and deployment
US20030135266A1 (en) * 2001-12-03 2003-07-17 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US7309350B2 (en) 2001-12-03 2007-12-18 Xtent, Inc. Apparatus and methods for deployment of vascular prostheses
US7351255B2 (en) * 2001-12-03 2008-04-01 Xtent, Inc. Stent delivery apparatus and method
US7294146B2 (en) 2001-12-03 2007-11-13 Xtent, Inc. Apparatus and methods for delivery of variable length stents
US7182779B2 (en) * 2001-12-03 2007-02-27 Xtent, Inc. Apparatus and methods for positioning prostheses for deployment from a catheter
US8080048B2 (en) * 2001-12-03 2011-12-20 Xtent, Inc. Stent delivery for bifurcated vessels
US7137993B2 (en) * 2001-12-03 2006-11-21 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US7147656B2 (en) * 2001-12-03 2006-12-12 Xtent, Inc. Apparatus and methods for delivery of braided prostheses
US20100016943A1 (en) 2001-12-20 2010-01-21 Trivascular2, Inc. Method of delivering advanced endovascular graft
US7241308B2 (en) * 2003-06-09 2007-07-10 Xtent, Inc. Stent deployment systems and methods
US20050080475A1 (en) * 2003-10-14 2005-04-14 Xtent, Inc. A Delaware Corporation Stent delivery devices and methods
US7553324B2 (en) * 2003-10-14 2009-06-30 Xtent, Inc. Fixed stent delivery devices and methods
US20070156225A1 (en) * 2003-12-23 2007-07-05 Xtent, Inc. Automated control mechanisms and methods for custom length stent apparatus
US7326236B2 (en) * 2003-12-23 2008-02-05 Xtent, Inc. Devices and methods for controlling and indicating the length of an interventional element
AU2005212335B2 (en) * 2004-02-09 2010-01-28 Cook Biotech, Inc. Cast bioremodelable graft
US7323006B2 (en) * 2004-03-30 2008-01-29 Xtent, Inc. Rapid exchange interventional devices and methods
US20050228477A1 (en) * 2004-04-09 2005-10-13 Xtent, Inc. Topographic coatings and coating methods for medical devices
US8623067B2 (en) 2004-05-25 2014-01-07 Covidien Lp Methods and apparatus for luminal stenting
US20060206200A1 (en) 2004-05-25 2006-09-14 Chestnut Medical Technologies, Inc. Flexible vascular occluding device
WO2005115118A2 (en) 2004-05-25 2005-12-08 Chestnut Medical Technologies, Inc. Flexible vascular occluding device
US8617234B2 (en) * 2004-05-25 2013-12-31 Covidien Lp Flexible vascular occluding device
EP2419048A4 (en) 2004-05-25 2014-04-09 Covidien Lp Vascular stenting for aneurysms
US8267985B2 (en) 2005-05-25 2012-09-18 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
US8317859B2 (en) 2004-06-28 2012-11-27 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US20050288766A1 (en) 2004-06-28 2005-12-29 Xtent, Inc. Devices and methods for controlling expandable prostheses during deployment
US20060069424A1 (en) * 2004-09-27 2006-03-30 Xtent, Inc. Self-constrained segmented stents and methods for their deployment
JP2008514345A (en) 2004-10-02 2008-05-08 クリストフ・ハンス・フーバー Device for treating or replacing a heart valve or surrounding tissue without requiring full cardiopulmonary support
US7641681B2 (en) * 2004-12-28 2010-01-05 Boston Scientific Scimed, Inc. Low profile stent-graft attachment
US8273101B2 (en) 2005-05-25 2012-09-25 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
CA2604081C (en) 2005-05-25 2013-11-26 Chestnut Medical Technologies, Inc. System and method for delivering and deploying a self-expanding device within a vessel
GB2427554B (en) * 2005-06-23 2007-05-23 Vascutek Ltd Aneurysm graft with markers
AU2006315812B2 (en) 2005-11-10 2013-03-28 Cardiaq Valve Technologies, Inc. Balloon-expandable, self-expanding, vascular prosthesis connecting stent
US8152833B2 (en) 2006-02-22 2012-04-10 Tyco Healthcare Group Lp Embolic protection systems having radiopaque filter mesh
WO2007109621A2 (en) * 2006-03-20 2007-09-27 Xtent, Inc. Apparatus and methods for deployment of linked prosthetic segments
WO2008013915A2 (en) 2006-07-28 2008-01-31 Arshad Quadri Percutaneous valve prosthesis and system and method for implanting same
US10137015B2 (en) * 2006-10-18 2018-11-27 Inspiremd Ltd. Knitted stent jackets
EP2083902B1 (en) * 2006-10-18 2017-08-30 Inspiremd Ltd. Filter assemblies
US20080099170A1 (en) * 2006-10-31 2008-05-01 The Procter & Gamble Company Process of making wet-microcontracted paper
US20080199510A1 (en) 2007-02-20 2008-08-21 Xtent, Inc. Thermo-mechanically controlled implants and methods of use
US8317856B2 (en) 2007-03-05 2012-11-27 Endospan Ltd. Multi-component expandable supportive bifurcated endoluminal grafts and methods for using same
US8486132B2 (en) 2007-03-22 2013-07-16 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US7766953B2 (en) * 2007-05-16 2010-08-03 Med Institute, Inc. Deployment system for an expandable stent
US20090076584A1 (en) * 2007-09-19 2009-03-19 Xtent, Inc. Apparatus and methods for deployment of multiple custom-length prostheses
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
CN101917929A (en) 2007-10-04 2010-12-15 特里瓦斯库拉尔公司 Modular vascular graft for low profile percutaneous delivery
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US8486131B2 (en) 2007-12-15 2013-07-16 Endospan Ltd. Extra-vascular wrapping for treating aneurysmatic aorta in conjunction with endovascular stent-graft and methods thereof
US9101503B2 (en) * 2008-03-06 2015-08-11 J.W. Medical Systems Ltd. Apparatus having variable strut length and methods of use
WO2009140437A1 (en) 2008-05-13 2009-11-19 Nfocus Neuromedical, Inc. Braid implant delivery systems
EP2282705A1 (en) 2008-06-04 2011-02-16 Gore Enterprise Holdings, Inc. Controlled deployable medical device and method of making the same
CA2727000C (en) 2008-06-04 2014-01-07 Gore Enterprise Holdings, Inc. Controlled deployable medical device and method of making the same
EP2293838B1 (en) 2008-07-01 2012-08-08 Endologix, Inc. Catheter system
US8821562B2 (en) 2008-09-25 2014-09-02 Advanced Bifurcation Systems, Inc. Partially crimped stent
WO2010036982A1 (en) 2008-09-25 2010-04-01 Henry Bourang Partially crimped stent
US11298252B2 (en) 2008-09-25 2022-04-12 Advanced Bifurcation Systems Inc. Stent alignment during treatment of a bifurcation
US8828071B2 (en) 2008-09-25 2014-09-09 Advanced Bifurcation Systems, Inc. Methods and systems for ostial stenting of a bifurcation
AU2009295960A1 (en) 2008-09-29 2010-04-01 Cardiaq Valve Technologies, Inc. Heart valve
AU2010236288A1 (en) 2009-04-15 2011-10-20 Cardiaq Valve Technologies, Inc. Vascular implant and delivery system
CA2961767C (en) 2009-06-23 2018-08-14 Endospan Ltd. Vascular prostheses for treating aneurysms
WO2011004374A1 (en) 2009-07-09 2011-01-13 Endospan Ltd. Apparatus for closure of a lumen and methods of using the same
WO2011064782A2 (en) 2009-11-30 2011-06-03 Endospan Ltd. Multi-component stent-graft system for implantation in a blood vessel with multiple branches
EP2509535B1 (en) 2009-12-08 2016-12-07 Endospan Ltd Endovascular stent-graft system with fenestrated and crossing stent-grafts
EP2519166A4 (en) 2009-12-31 2017-06-14 Endospan Ltd Endovascular flow direction indicator
CA2789304C (en) 2010-02-08 2018-01-02 Endospan Ltd. Thermal energy application for prevention and management of endoleaks in stent-grafts
CN103037815B (en) 2010-03-24 2015-05-13 高级分支系统股份有限公司 Methods and systems for treating a bifurcation with provisional side branch stenting
CN109363807B (en) 2010-03-24 2021-04-02 高级分支系统股份有限公司 System and method for treating a bifurcation
EP2549951B1 (en) 2010-03-24 2017-05-10 Advanced Bifurcation Systems, Inc. Stent alignment during treatment of a bifurcation
CA2803149C (en) 2010-06-21 2018-08-14 Impala, Inc. Replacement heart valve
EP2618784B1 (en) 2010-09-23 2016-05-25 Edwards Lifesciences CardiAQ LLC Replacement heart valves and delivery devices
CA2826022A1 (en) 2011-02-03 2012-08-09 Endospan Ltd. Implantable medical devices constructed of shape memory material
CA2826760A1 (en) 2011-02-08 2012-08-16 Advanced Bifurcation Systems, Inc. Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use
EP3777780A1 (en) 2011-02-08 2021-02-17 Advanced Bifurcation Systems Inc. System for treating a bifurcation with a fully crimped stent
WO2012111006A1 (en) 2011-02-17 2012-08-23 Endospan Ltd. Vascular bands and delivery systems therefor
US8808350B2 (en) 2011-03-01 2014-08-19 Endologix, Inc. Catheter system and methods of using same
WO2012117395A1 (en) 2011-03-02 2012-09-07 Endospan Ltd. Reduced-strain extra- vascular ring for treating aortic aneurysm
US8574287B2 (en) 2011-06-14 2013-11-05 Endospan Ltd. Stents incorporating a plurality of strain-distribution locations
ES2568377T3 (en) 2011-06-21 2016-04-28 Endospan Ltd Endovascular system with circumferentially overlapping stents
EP2729095B1 (en) 2011-07-07 2016-10-26 Endospan Ltd. Stent fixation with reduced plastic deformation
WO2013030818A2 (en) 2011-08-28 2013-03-07 Endospan Ltd. Stent-grafts with post-deployment variable axial and radial displacement
WO2013065040A1 (en) 2011-10-30 2013-05-10 Endospan Ltd. Triple-collar stent-graft
WO2013084235A2 (en) 2011-12-04 2013-06-13 Endospan Ltd. Branched stent-graft system
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
WO2013171730A1 (en) 2012-05-15 2013-11-21 Endospan Ltd. Stent-graft with fixation elements that are radially confined for delivery
US9155647B2 (en) 2012-07-18 2015-10-13 Covidien Lp Methods and apparatus for luminal stenting
US20140052160A1 (en) * 2012-08-16 2014-02-20 Devinder Singh Open surgery anastomosis device, system, and method
US9301831B2 (en) 2012-10-30 2016-04-05 Covidien Lp Methods for attaining a predetermined porosity of a vascular device
US9452070B2 (en) 2012-10-31 2016-09-27 Covidien Lp Methods and systems for increasing a density of a region of a vascular device
US9943427B2 (en) 2012-11-06 2018-04-17 Covidien Lp Shaped occluding devices and methods of using the same
US9993360B2 (en) 2013-01-08 2018-06-12 Endospan Ltd. Minimization of stent-graft migration during implantation
US9157174B2 (en) 2013-02-05 2015-10-13 Covidien Lp Vascular device for aneurysm treatment and providing blood flow into a perforator vessel
US9668892B2 (en) 2013-03-11 2017-06-06 Endospan Ltd. Multi-component stent-graft system for aortic dissections
US9730791B2 (en) 2013-03-14 2017-08-15 Edwards Lifesciences Cardiaq Llc Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US20140277427A1 (en) 2013-03-14 2014-09-18 Cardiaq Valve Technologies, Inc. Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
WO2015075708A1 (en) 2013-11-19 2015-05-28 Endospan Ltd. Stent system with radial-expansion locking
CA2938614C (en) 2014-02-21 2024-01-23 Edwards Lifesciences Cardiaq Llc Delivery device for controlled deployement of a replacement valve
US20150328000A1 (en) 2014-05-19 2015-11-19 Cardiaq Valve Technologies, Inc. Replacement mitral valve with annular flap
CA2967904C (en) 2014-12-18 2023-01-10 Endospan Ltd. Endovascular stent-graft with fatigue-resistant lateral tube
US10376363B2 (en) 2015-04-30 2019-08-13 Edwards Lifesciences Cardiaq Llc Replacement mitral valve, delivery system for replacement mitral valve and methods of use
WO2016209970A1 (en) 2015-06-22 2016-12-29 Edwards Lifescience Cardiaq Llc Actively controllable heart valve implant and methods of controlling same
US10092400B2 (en) 2015-06-23 2018-10-09 Edwards Lifesciences Cardiaq Llc Systems and methods for anchoring and sealing a prosthetic heart valve
JP2018524025A (en) 2015-06-30 2018-08-30 エンドロジックス、インク Lock assembly for coupling guidewire to delivery system
US10575951B2 (en) 2015-08-26 2020-03-03 Edwards Lifesciences Cardiaq Llc Delivery device and methods of use for transapical delivery of replacement mitral valve
US10117744B2 (en) 2015-08-26 2018-11-06 Edwards Lifesciences Cardiaq Llc Replacement heart valves and methods of delivery
US10350066B2 (en) 2015-08-28 2019-07-16 Edwards Lifesciences Cardiaq Llc Steerable delivery system for replacement mitral valve and methods of use
EP3349687B1 (en) 2015-09-15 2020-09-09 THE UNITED STATES OF AMERICA, represented by the S Devices for effectuating percutaneous glenn and fontan procedures
WO2019010321A1 (en) 2017-07-06 2019-01-10 Edwards Lifesciences Corporation Steerable rail delivery system
WO2019147846A2 (en) 2018-01-25 2019-08-01 Edwards Lifesciences Corporation Delivery system for aided replacement valve recapture and repositioning post- deployment
US11051934B2 (en) 2018-02-28 2021-07-06 Edwards Lifesciences Corporation Prosthetic mitral valve with improved anchors and seal
US11376144B2 (en) 2018-11-12 2022-07-05 Cook Medical Technologies Llc Systems and methods to position a prosthesis
EP3941392A1 (en) 2019-03-20 2022-01-26 Inqb8 Medical Technologies, LLC Aortic dissection implant
CA3155997A1 (en) 2019-09-25 2021-04-01 Aquedeon Medical, Inc. Vascular and aortic grafts and deployment tools
MX2022010898A (en) * 2020-03-04 2022-09-29 Aquedeon Medical Inc Vascular and aortic connectors with telescoping sheath and deployment methods thereof.
WO2023056027A1 (en) * 2021-10-01 2023-04-06 Reflow Medical, Inc. Delivery systems

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5201757A (en) * 1992-04-03 1993-04-13 Schneider (Usa) Inc. Medial region deployment of radially self-expanding stents
US5415664A (en) * 1994-03-30 1995-05-16 Corvita Corporation Method and apparatus for introducing a stent or a stent-graft
US5693083A (en) * 1983-12-09 1997-12-02 Endovascular Technologies, Inc. Thoracic graft and delivery catheter
US6117166A (en) * 1997-10-27 2000-09-12 Winston; Thomas R. Apparatus and methods for grafting blood vessel tissue
US6350278B1 (en) * 1994-06-08 2002-02-26 Medtronic Ave, Inc. Apparatus and methods for placement and repositioning of intraluminal prostheses

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108416A (en) * 1990-02-13 1992-04-28 C. R. Bard, Inc. Stent introducer system
US5578071A (en) * 1990-06-11 1996-11-26 Parodi; Juan C. Aortic graft
US5383928A (en) * 1992-06-10 1995-01-24 Emory University Stent sheath for local drug delivery
IL108455A (en) * 1993-01-27 1997-04-15 Instent Inc Vascular and coronary stents
WO1994023786A1 (en) * 1993-04-13 1994-10-27 Boston Scientific Corporation Prosthesis delivery system
AU689094B2 (en) * 1993-04-22 1998-03-26 C.R. Bard Inc. Non-migrating vascular prosthesis and minimally invasive placement system therefor
US5480423A (en) * 1993-05-20 1996-01-02 Boston Scientific Corporation Prosthesis delivery
US5989280A (en) 1993-10-22 1999-11-23 Scimed Lifesystems, Inc Stent delivery apparatus and method
US5683451A (en) * 1994-06-08 1997-11-04 Cardiovascular Concepts, Inc. Apparatus and methods for deployment release of intraluminal prostheses
EP0790810B1 (en) * 1994-11-09 2004-04-28 Endotex Interventional Systems, Inc. Kit of delivery catheter and graft for aneurysm repair
CA2218072A1 (en) * 1995-04-14 1996-10-17 Schneider (Usa) Inc. Rolling membrane stent delivery device
US5980530A (en) * 1996-08-23 1999-11-09 Scimed Life Systems Inc Stent delivery system
US5954764A (en) * 1996-09-20 1999-09-21 Parodi; Juan Carlos Device for concurrently placing an endovascular expander with an endovascular prosthesis
FR2756173B1 (en) 1996-11-22 1999-02-12 Marcade Jean Paul MODULAR AND EXPANDABLE ENDOPROSTHESIS FOR THE ARTERIAL NETWORK
AUPO700897A0 (en) 1997-05-26 1997-06-19 William A Cook Australia Pty Ltd A method and means of deploying a graft
US5948017A (en) * 1997-10-12 1999-09-07 Taheri; Syde A. Modular graft assembly
US6280467B1 (en) * 1998-02-26 2001-08-28 World Medical Manufacturing Corporation Delivery system for deployment and endovascular assembly of a multi-stage stented graft
US6325820B1 (en) * 1998-11-16 2001-12-04 Endotex Interventional Systems, Inc. Coiled-sheet stent-graft with exo-skeleton
US6336937B1 (en) * 1998-12-09 2002-01-08 Gore Enterprise Holdings, Inc. Multi-stage expandable stent-graft
US6162246A (en) * 1999-02-16 2000-12-19 Barone; Hector Daniel Aortic graft and method of treating abdominal aortic aneurysms
JP2000262632A (en) * 1999-03-18 2000-09-26 Arata Ishimaru Sent (or sent graft) detention device
US6623518B2 (en) * 2001-02-26 2003-09-23 Ev3 Peripheral, Inc. Implant delivery system with interlock

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693083A (en) * 1983-12-09 1997-12-02 Endovascular Technologies, Inc. Thoracic graft and delivery catheter
US6346118B1 (en) * 1983-12-09 2002-02-12 Endovascular Technologies, Inc. Thoracic graft and delivery catheter
US5201757A (en) * 1992-04-03 1993-04-13 Schneider (Usa) Inc. Medial region deployment of radially self-expanding stents
US5415664A (en) * 1994-03-30 1995-05-16 Corvita Corporation Method and apparatus for introducing a stent or a stent-graft
US6350278B1 (en) * 1994-06-08 2002-02-26 Medtronic Ave, Inc. Apparatus and methods for placement and repositioning of intraluminal prostheses
US6117166A (en) * 1997-10-27 2000-09-12 Winston; Thomas R. Apparatus and methods for grafting blood vessel tissue

Also Published As

Publication number Publication date
WO2004021932A1 (en) 2004-03-18
US20040044395A1 (en) 2004-03-04
JP2005537107A (en) 2005-12-08
JP4624103B2 (en) 2011-02-02
AU2003251299A1 (en) 2004-03-29
US8518096B2 (en) 2013-08-27
EP1545397A1 (en) 2005-06-29
CA2497704A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
US8518096B2 (en) Elephant trunk thoracic endograft and delivery system
US7556643B2 (en) Graft inside stent
US10603197B2 (en) Stent system with radial-expansion locking
EP0689806B1 (en) Implantable tubular prosthesis having cuffs
US5556414A (en) Composite intraluminal graft
JP4067634B2 (en) Stent
JP4021882B2 (en) Implant deployment placement device
US6663665B2 (en) Single puncture bifurcation graft deployment system
EP1513471B1 (en) Endoluminal device having barb assembly
EP1000590B1 (en) An improved stent which is easly recaptured and repositioned within the body
US6093203A (en) Stent or graft support structure for treating bifurcated vessels having different diameter portions and methods of use and implantation
US6348066B1 (en) Modular endoluminal stent-grafts and methods for their use
US6344054B1 (en) Endoluminal prosthesis comprising stent and overlying graft cover, and system and method for deployment thereof
EP1808149A1 (en) Intraluminal stent graft
WO1998020810A1 (en) Flexible, radially expansible luminal prostheses
EP0861638B1 (en) Modular endoluminal stent-grafts
JP3679810B2 (en) Graft delivery system
AU2012238416B2 (en) Apparatus for deploying a stent graft

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION